Table 1 |
||||||
|
Overview of CycT1 mutants used in this study. |
||||||
| Regions |
Helix# |
Amino acid positions |
# of clones |
Activity in murine cells (*1) |
||
|
|
||||||
| >100% |
50–100% |
<50% |
||||
|
|
||||||
| Region 1 |
2 |
58–65 |
29 |
4 |
14 |
11 |
| Region 2 |
2 |
67–71 |
26 |
3 |
10 |
13 |
| Region 3 |
3 |
88–91 |
16 |
2 |
5 |
9 |
| Region 4 |
3 |
93–96 |
16 |
3 |
11 |
2 |
| Region 5 |
4 |
104–108 |
5 |
0 |
0 |
5 |
| Region 6 |
5 |
132–137 |
3 |
0 |
1 |
2 |
| Region 7 |
5 |
139–143 |
9 |
0 |
0 |
9 |
| Region 8 |
5 |
145–148 |
2 |
0 |
0 |
2 |
| Region 9 |
1' |
149–152 |
9 |
3 |
4 |
2 |
|
|
||||||
| total |
115 |
15 |
45 |
55 |
||
|
|
||||||
|
*1: Tat transactivation obtained with wt human CycT1 is set as 100% |
||||||
|
Jadlowsky et al. Retrovirology 2008 5:63 doi:10.1186/1742-4690-5-63 |
||||||